Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules Dienstag

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|April 26, 2007
TelbivudineJules Dienstag, Chris Easley, Peter Kirkpatrick
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis BChing-Lung Lai, Jules Dienstag, Eugene Schiff, et al.
Gastroenterology|October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CJohn G McHutchison, Michael Manns, Keyur Patel, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|April 26, 2007
TelbivudineJules Dienstag, Chris Easley, Peter Kirkpatrick
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis BChing-Lung Lai, Jules Dienstag, Eugene Schiff, et al.
Gastroenterology|October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CJohn G McHutchison, Michael Manns, Keyur Patel, et al.
Pageof 1